Ben Dijk
Directeur/Membre du Conseil chez SurgVision BV
Profil
Ben Dijk currently works at SurgVision BV, as Member-Supervisory Board.
Mr. Dijk also formerly worked at DFZ Participaties BV, as Managing Director from 2016 to 2019, Friesland Bank Investments BV, as Investment Manager from 2000 to 2010, and Hemics BV, as Member-Supervisory Board.
Mr. Dijk received his Masters Business Admin degree from the University of Groningen.
Postes actifs de Ben Dijk
| Sociétés | Poste | Début |
|---|---|---|
SurgVision BV
 SurgVision BV Medical SpecialtiesHealth Technology SurgVision BV provides optical imaging camera systems. It develops integrated optical imaging platforms, including camera, software and target specific tracer, for specific disease areas like breast cancer surgery. The company was founded by Vasilis Ntziachristos and Ton van den Hoven in 2011 and is headquartered in 't Harde, the Netherlands. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ben Dijk
| Sociétés | Poste | Fin |
|---|---|---|
DFZ Participaties BV
 DFZ Participaties BV Investment ManagersFinance DFZ Participaties BV is an independent private equity firm with its headquarters in Leeuwarden, the Netherlands. It was founded in 2010. | Director of Investments | 01/12/2016 |
Friesland Bank Investments BV
 Friesland Bank Investments BV Investment ManagersFinance Friesland Bank Investments BV (FBI) is the wholly-owned subsidiary of Friesland Bank NV in the Netherlands. Established in 1982, FBI is a private equity firm which focuses on medium-sized enterprises. Located in Leeuwarden, Enschede and Amsterdam, the firm participates in a range of private equity investments, including expansions, takeovers, MBOs, family business successions and delistings. | Private Equity Investor | 01/01/2010 |
Hemics BV
 Hemics BV Medical SpecialtiesHealth Technology Hemics BV develops and manufactures medical imaging devices. Its systems are based on patented optical inflammation detection technology, a non-invasive, fast and operator independent method that supports rheumatologists in objective assessment of inflammatory status, a key parameter in the treatment of patients with RA. The company was founded by Wouter Rensen, Michiel van Beek and Petra van den Elsen on September 1, 2011 and is headquartered in Eindhoven, the Netherlands. | Directeur/Membre du Conseil | - |
Formation de Ben Dijk
| University of Groningen | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Friesland Bank Investments BV
Friesland Bank Investments BV Investment ManagersFinance Friesland Bank Investments BV (FBI) is the wholly-owned subsidiary of Friesland Bank NV in the Netherlands. Established in 1982, FBI is a private equity firm which focuses on medium-sized enterprises. Located in Leeuwarden, Enschede and Amsterdam, the firm participates in a range of private equity investments, including expansions, takeovers, MBOs, family business successions and delistings. | Finance |
DFZ Participaties BV
DFZ Participaties BV Investment ManagersFinance DFZ Participaties BV is an independent private equity firm with its headquarters in Leeuwarden, the Netherlands. It was founded in 2010. | Finance |
Hemics BV
Hemics BV Medical SpecialtiesHealth Technology Hemics BV develops and manufactures medical imaging devices. Its systems are based on patented optical inflammation detection technology, a non-invasive, fast and operator independent method that supports rheumatologists in objective assessment of inflammatory status, a key parameter in the treatment of patients with RA. The company was founded by Wouter Rensen, Michiel van Beek and Petra van den Elsen on September 1, 2011 and is headquartered in Eindhoven, the Netherlands. | Health Technology |
SurgVision BV
SurgVision BV Medical SpecialtiesHealth Technology SurgVision BV provides optical imaging camera systems. It develops integrated optical imaging platforms, including camera, software and target specific tracer, for specific disease areas like breast cancer surgery. The company was founded by Vasilis Ntziachristos and Ton van den Hoven in 2011 and is headquartered in 't Harde, the Netherlands. | Health Technology |
